Singapore-based pharmaceutical and consumer healthcare group Hyphens Pharma International on Friday launched its initial public offering (IPO) on the Catalist board of the SGX.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
